Mckesson Corporation
- UEI
- S1RUKWWRYFL6
- EIN
- 94-3207296
- Registro en SAM.gov
- Aún sin consultar
- Dirección física
- 6555 STATE HWY 161, IRVING, TX 75039
Resumen forense
MCKESSON CORPORATION es una empresa con sede en Irving, Texas, y opera bajo su propio nombre. En nuestros registros, la empresa tiene 239 contratos con el gobierno federal de EE.UU., con un monto total comprometido de 13.4 mil millones de dólares. El Departamento de Veteranos es el principal organismo con el que MCKESSON ha realizado negocios, representando el 98% del valor total de sus contratos. Otros organismos importantes incluyen al Departamento de Justicia y al Departamento de Salud y Servicios Humanos. Las industrias principales de la empresa son la fabricación de preparados farmacéuticos y el comercio mayorista de medicamentos y artículos de farmacia. MCKESSON está cotizada en bolsa bajo el ticker de acciones MCK. Su primer contrato en nuestros registros fue registrado el 1 de octubre de 2025, y el más reciente fue el 22 de octubre de 2026.
MCKESSON CORPORATION tiene un puntaje de riesgo de 5 sobre 100, lo que indica un nivel bajo de riesgo. El único indicador de riesgo identificado es que su ingreso está concentrado en un solo organismo, el Departamento de Veteranos, que representa el 98% de su valor total de contratos. Esta concentración podría indicar una dependencia potencial de un solo organismo, lo que podría representar un riesgo si ese organismo reduce sus gastos o cambia sus prácticas de adquisición. Sin embargo, esto se considera una señal estadística que merece revisión y no una evidencia de mala conducta.
Redactado por IA solo con los datos de esta página. Revisa las fuentes enlazadas antes de usarlo.
Indicadores de riesgo
- Ingresos concentrados en una sola agencia · share: 98%, agency: Department of Veterans Affairs+5
El score suma indicadores estadísticos de registros públicos. Sirve para priorizar una revisión; no prueba ninguna falta.
Seguridad laboral (OSHA, últimos 10 años)
No encontramos inspecciones de OSHA para este establecimiento.
Coincidencia por nombre y código postal del establecimiento. Una inspección no implica infracción; las multas pueden reducirse en apelación. Fuente: Departamento de Trabajo de EE. UU.
Datos de bolsa y financieros (SEC)
Esta empresa cotiza en bolsa · MCK · SEC EDGAR
| Año fiscal | Ingresos | Utilidad neta | Flujo operativo | Activos | Patrimonio | Deuda a largo plazo |
|---|---|---|---|---|---|---|
| 2025 | USD 403.4 mil M | USD 5099 M | USD 6155 M | — | — | — |
| 2024 | USD 359.1 mil M | USD 3481 M | USD 6085 M | — | — | — |
| 2023 | USD 309 mil M | USD 3160 M | USD 4314 M | — | — | — |
| 2022 | USD 276.7 mil M | USD 3722 M | USD 5159 M | — | — | — |
| 2021 | USD 264 mil M | USD 1287 M | USD 4434 M | — | — | — |
Hechos relevantes (8-K) de los últimos 3 años
- 6 oct 2026 8-K · Divulgación (Reg FD)
- 28 ago 2026 8-K · Divulgación (Reg FD)
- 5 ago 2026 8-K · Resultados financieros
- 24 jul 2026 8-K · Votación de accionistas
- 1 jul 2026 8-K · Cambio de directores o ejecutivos, Divulgación (Reg FD)
- 12 jun 2026 8-K · Acuerdo relevante, Nueva obligación financiera
- 7 may 2026 8-K · Resultados financieros
- 28 abr 2026 8-K · Acuerdo relevante, Terminación de acuerdo relevante, Nueva obligación financiera
- 6 abr 2026 8-K · Acuerdo relevante, Nueva obligación financiera
- 6 mar 2026 8-K · Divulgación (Reg FD)
- 5 mar 2026 8-K · Cambio de directores o ejecutivos
- 4 feb 2026 8-K · Resultados financieros
Cifras anuales de los informes oficiales presentados a la SEC (XBRL). La dependencia compara los contratos federales firmados por las empresas del grupo en los últimos 12 meses (monto total del contrato, que puede abarcar varios años) con los ingresos del último año: es una referencia, no una cifra contable. No incluye precios de la acción.
Presencia digital y ciberseguridad
mckesson.com · web oficial (Wikidata)
- ✓ HTTPS válido
- ✓ HSTS activo
- ✗ Sin política de contenido (CSP)
- ✓ Protección contra clickjacking
- ✓ SPF estricta (-all)
- ✓ DMARC rechazar (reject)
Tecnología detectada: Google Analytics / Tag ManagerMarketojQuery
Revisión pasiva del 29 oct 2026: solo lo que cualquier navegador ve al abrir la portada y lo que el dominio publica en el DNS (sin escaneos ni pruebas). Es una referencia de buenas prácticas básicas, no una auditoría de seguridad; la ausencia de una cabecera no implica una vulnerabilidad.
Identidad legal y jerarquía (LEI)
LEI 549300WZWOM80UCFSF54 · Mckesson Corporation · US-DE · vigente
- Mckesson Medical-Surgical Top Holdings INC. · US-FL
- Mckesson Uk Finance II Limited · GB
- P.C.B. · BE-BRU
Datos del Global Legal Entity Identifier Foundation (GLEIF), con licencia CC0. La jerarquía la declara cada empresa al registrar su LEI; muchas filiales no tienen LEI propio.
Transporte y logística (USDOT / FMCSA)
Todos sus registros USDOT figuran inactivos.
| USDOT | MC | Estado | Operación | Flota | Seguridad | Inspecc. 24 m | Fuera de servicio (veh./cond.) | Choques 24 m | Seguros vigentes |
|---|---|---|---|---|---|---|---|---|---|
| 50541 IRVING, TX | — | Inactivo | Interestatal | 1 | — | — | — / — | — | — |
| 257500 PHOENIX, AZ | — | Inactivo | Interestatal | 0 | — | — | — / — | — | — |
| 280031 SAN FRANSISCO, CA | — | Inactivo | Intraestatal | 0 | — | — | — / — | — | — |
Datos abiertos de la FMCSA (Departamento de Transporte de EE. UU.): censo MCS-150, inspecciones en carretera y choques de los últimos 24 meses y seguros registrados. La tasa fuera de servicio es aproximada (infracciones que dejaron el vehículo o al conductor fuera de servicio por cada inspección del tipo correspondiente). Muchas empresas registran un número USDOT por división; se enlazan por nombre legal exacto.
Telecomunicaciones (FCC)
Servicios: Radio privada · 10
Licencias del Sistema Universal de Licencias (ULS) de la FCC, archivo semanal completo; titulares de FCC ID del registro oficial de la FCC. Se enlazan por nombre legal exacto del titular; cada FCC ID empieza por el código de titular.
Gobierno corporativo (SEC)
Directivos y accionistas de más del 10 %
| Fraga Francisco | EVP, CIO and CTO | 19 oct 2026 |
| Rodgers Thomas L | EVP, Chief Strategy & BDO | 3 jun 2026 |
| Rutledge Napoleon B Jr | SVP, Controller & CAO | 10 sept 2026 |
| Srinivasan Ramesh (Nmn) | EVP and Chief Strategy Officer | 11 ago 2026 |
| Tyler Brian S. | Director · Chief Executive Officer | 8 jul 2026 |
| Caruso Dominic J | Director | 23 jul 2026 |
| Doughtie Lynne M | Director | 23 jul 2026 |
| Dunbar Webster Roy | Director | 23 jul 2026 |
| Dunsire Deborah | Director | 23 jul 2026 |
| Gerberding Julie L. | Director | 23 jul 2026 |
| Hinton James H. | Director | 23 jul 2026 |
| Lerman Bradley E | Director | 11 ago 2026 |
| Martinez Maria | Director | 23 jul 2026 |
| Ozan Kevin M | Director | 23 jul 2026 |
| Wilson-Thompson Kathleen | Director | 23 jul 2026 |
Directivos y accionistas según los formularios 3 y 4 más recientes; filiales según el anexo 21 del último informe anual (10-K). Una coincidencia de nombre no prueba identidad. Fuente: SEC EDGAR.
Entidades vinculadas
No se encontraron entidades vinculadas.
Los vínculos salen de direcciones físicas compartidas, directivos declarados y empresas matrices. Un vínculo no es una acusación.
Historial de contratos
| Contrato | Agencia | Descripción | Firma | Obligado | Adendas | Obligado / techo | Competencia |
|---|---|---|---|---|---|---|---|
| 15B20527F00000022 | Federal Prison System / Bureau Of Prisons | FY27 INTERAGENCY AGREEMENT PHARMACEUTICALS FOR FMC DEVENS. | 22 oct 2026 | USD 2,000,000 | 0 | ×1.00 | Competido |
| 15B51926F00000155 | Federal Prison System / Bureau Of Prisons | BIKTARVY #376-0550 6624 BOTTLES | 10 sept 2026 | USD 15,157,964 | 0 | ×1.00 | Competido |
| 36C24026K1011 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 AUG | 1 ago 2026 | USD 1,159,388,670 | 0 | ×1.00 | Competido |
| 36C24026K1010 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JULY | 1 jul 2026 | USD 1,194,619,137 | 0 | ×1.00 | Competido |
| 36C24026K1009 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JUNE | 1 jun 2026 | USD 1,191,973,258 | 0 | ×1.00 | Competido |
| 36C24026K1008 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MAY | 1 may 2026 | USD 1,398,025,092 | 0 | ×1.00 | Competido |
| 36C24026K1007 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL | 1 abr 2026 | USD 1,191,348,081 | 0 | ×1.00 | Competido |
| 36C24026K1006 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MARCH | 1 mar 2026 | USD 1,175,683,451 | 0 | ×1.00 | Competido |
| 36C24026K1005 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 FEBRUARY | 1 feb 2026 | USD 1,060,268,795 | 0 | ×1.00 | Competido |
| 70CDCR26FR0000011 | U.S. Immigration And Customs Enforcement | THE PURPOSE OF THIS CONTRACT IS TO PROVIDE ICE HEALTH SERVICE CORPS WITH PHARMACEUTICAL PRODUCTS. | 30 ene 2026 | USD 18,592,000 | 2 | ×1.00 | Competido |
| 36C24026K1004 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY | 1 ene 2026 | USD 1,087,989,766 | 0 | ×1.00 | Competido |
| 15B10626F00000037 | Federal Prison System / Bureau Of Prisons | MCKESSON: NON-CONTROLLED MEDICATION DOS: OCTOBER 1, 2025 THRU DECEMBER 31, 2025. | 3 dic 2025 | USD 24,534,880 | 6 | ×1.00 | Competido |
| 36C24026K1003 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER | 1 dic 2025 | USD 1,110,402,104 | 0 | ×1.00 | Competido |
| 36C24026K1002 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER | 1 nov 2025 | USD 1,406,868,182 | 0 | ×1.00 | Competido |
| 36C24026K1001 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER | 1 oct 2025 | USD 1,184,200,532 | 0 | ×1.00 | Competido |
| 75H71126F80006 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR PURCHASES FOR NSSC FEDERAL CUSTOMERS. | — | USD 9,000,000 | 0 | — | — |
| 75H71126F80016 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR PURCHASES FOR NSSC CUSTOMERS. | — | USD 9,000,000 | 0 | — | — |
| 75H71126F80018 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR PURCHASES FOR NSSC CUSTOMERS. | — | USD 9,000,000 | 0 | — | — |
| 75H71126F80024 | Indian Health Service | DELIVERY ORDER FOR ADDITIONAL FUNDING FOR NSSC PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR PURCHASES. | — | USD 9,000,000 | 0 | — | — |
| 75H71126F80030 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PPV PURCHASES FOR NSSC CUSTOMERS. | — | USD 9,000,000 | 0 | — | — |
| 75H71126F80029 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR (IDIQ) PURCHASES FOR NSSC CUSTOMERS. | — | USD 9,000,000 | 0 | — | — |
| 75H71126F80034 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR (IDIQ) PURCHASES FOR NSSC CUSTOMERS. | — | USD 9,000,000 | 0 | — | — |
| 75H71126F80023 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PPV PURCHASES FOR NSSC CUSTOMERS. | — | USD 8,000,000 | 0 | — | — |
| 75H71126F80009 | Indian Health Service | PHARMACEUTICAL SUPPLIES. PHARMACY PRIME VENDOR PURCHASES FOR NSSC FEDERAL CUSTOMERS. | — | USD 5,505,870 | 0 | — | — |
| 15B10626F00000172 | Federal Prison System / Bureau Of Prisons | MCKESSON: NON-CONTROLLED MEDICATION DOS: AUGUST 10, 2026- SEPTEMBER 30, 2026 | — | USD 5,000,000 | 0 | — | — |
| 15B50926F00000006 | Federal Prison System / Bureau Of Prisons | MCKESSON PHARMACEUTICALS FOR INMATES AT FMC FORT WORTH | — | USD 4,581,049 | 0 | — | — |
| 75H71126F80014 | Indian Health Service | PHARMACEUTICAL SUPPLIES. PHARMACY PRIME VENDOR PURCHASES FOR NSSC FEDERAL CUSTOMERS. | — | USD 4,500,000 | 0 | — | — |
| 15B51926F00000129 | Federal Prison System / Bureau Of Prisons | PHARMACEUTICALS | — | USD 4,460,593 | 0 | — | — |
| 75H71126F80013 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR PURCHASES FOR NSSC CUSTOMERS. | — | USD 4,000,000 | 0 | — | — |
| 75H71126F80035 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR (IDIQ) PURCHASES FOR NSSC CUSTOMERS. | — | USD 4,000,000 | 0 | — | — |
| 15B20526F00000003 | Federal Prison System / Bureau Of Prisons | PPV PHARMACEUTICAL ITEMS - FISCAL YEAR 26 | — | USD 3,464,920 | 0 | — | — |
| 75H71126F80005 | Indian Health Service | DELIVERY ORDER FOR PHARMACEUTICAL SUPPLIES, PRIME PHARMACY VENDOR PURCHASES FOR NSSC FEDERAL CUSTOMERS. | — | USD 3,358,127 | 0 | — | — |
| 70CDCR26FR0000037 | U.S. Immigration And Customs Enforcement | THIS CONTRACT IS TO RATIFY AN UNAUTHORIZED COMMITMENT FOR PHARMACEUTICALS FOR THE ICE HEALTH SERVICE CORPS. | — | USD 3,164,400 | 0 | — | — |
| 75H71126F80003 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PRIME PHARMACY VENDOR PURCHASES FOR NSSC FEDERAL CUSTOMERS. | — | USD 3,000,000 | 0 | — | — |
| 75H71126F80019 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR PURCHASES FOR NSSC CUSTOMERS. | — | USD 3,000,000 | 0 | — | — |
| 75H71126F80002 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PPV PURCHASES FOR NSSC FEDERAL CUSTOMERS. | — | USD 2,819,494 | 0 | — | — |
| 15B51926F00000156 | Federal Prison System / Bureau Of Prisons | 322-9069 JARDIANCE 10MG 2940 BOTTLES | — | USD 2,439,524 | 0 | — | — |
| 15B20526F00000108 | Federal Prison System / Bureau Of Prisons | PPV PHARMACEUTICAL ITEMS | — | USD 2,247,849 | 0 | — | — |
| 75H71126F80001 | Indian Health Service | PHARMACEUTICAL SUPPLIES, OPEN MARKET PURCHASES FOR NSSC FEDERAL CUSTOMERS. | — | USD 2,000,000 | 0 | — | — |
| 15B10926F00000075 | Federal Prison System / Bureau Of Prisons | PHARMACEUTICAL PRIME VENDOR CONTRACT - MEDICATIONS FOR THE INMATE POPULATION | — | USD 1,899,069 | 0 | — | — |
| 15B61526F00000009 | Federal Prison System / Bureau Of Prisons | OATS - TCX-FY26-B1-MCKESSON-AIC PHARMACEUTICALS | — | USD 1,856,003 | 0 | — | — |
| 15B41726F00000006 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON CONTRACT ANNUAL | — | USD 1,616,794 | 0 | — | — |
| 75H71226F80005 | Indian Health Service | DELIVERY ORDER AGAINST 36W79720D0001, MCKESSON VA MEDSURGE PRIME VENDOR FOR PHARMACEUTICAL SUPPLIES FOR THE P… | — | USD 1,600,000 | 0 | — | — |
| 15B30326F00000002 | Federal Prison System / Bureau Of Prisons | FY 25 MCKESSON CONTRACT | — | USD 1,500,152 | 0 | — | — |
| 15B50526F00000172 | Federal Prison System / Bureau Of Prisons | FY 26 STANDARD MEDICATION - 4TH QTR JULY - SEPT | — | USD 1,472,476 | 0 | — | — |
| 15B50526F00000122 | Federal Prison System / Bureau Of Prisons | FY 26 STANDARD MEDICATION - APRIL - JUNE | — | USD 1,341,301 | 0 | — | — |
| 15B12026F00000005 | Federal Prison System / Bureau Of Prisons | FY26 MCKESSON MEDICATION 1ST QTR OCTOBER-DECEMBER 2025 | — | USD 1,275,615 | 0 | — | — |
| 15B50526F00000074 | Federal Prison System / Bureau Of Prisons | FY 26 STANDARD MEDICATION - JANUARY - MARCH | — | USD 1,251,354 | 0 | — | — |
| 15B51526F00000004 | Federal Prison System / Bureau Of Prisons | MCKESSON NON-CONTRACT MEDICATION 10/23/2025 THROUGH 10/31/2025. ACCOUNT NUMBER: 321045 | — | USD 1,146,029 | 0 | — | — |
| 15B20126F00000092 | Federal Prison System / Bureau Of Prisons | 4TH QUARTER REGULAR DRUGS COVERING 7/01/2026 THROUGH 9/30/2026 DELIVERY DATES FROM 7/01/2026 THROUGH 9/30/202… | — | USD 1,047,617 | 0 | — | — |
| 15B50526F00000032 | Federal Prison System / Bureau Of Prisons | FY 26 STANDARD MEDICATION | — | USD 1,024,614 | 0 | — | — |
| 15B51926F00000157 | Federal Prison System / Bureau Of Prisons | 368-6052 VOSEVI 54 BOTTLES | — | USD 1,017,949 | 0 | — | — |
| 15B61726F00000107 | Federal Prison System / Bureau Of Prisons | FCC LOMPOC MCKESSON REGULAR MEDICATIONS MARCH 1, 2026 - AUGUST 9, 2026 | — | USD 1,006,736 | 0 | — | — |
| 15B20526F00000135 | Federal Prison System / Bureau Of Prisons | PPV PHARMACEUTICAL ITEMS - OY3 FY26 AUG 10, 2026 - SEP 30, 2026 EO 14398 NEED INCREASE TO PAY OUTSTANDI… | — | USD 991,074 | 0 | — | — |
| 15B20126F00000078 | Federal Prison System / Bureau Of Prisons | 3RD QUARTER REGULAR DRUGS COVERING 4/01/2026 THROUGH 6/30/2026 DELIVERY DATES FROM 4/01/2026 THROUGH 6/30/202… | — | USD 949,985 | 0 | — | — |
| 15BBR026F00000013 | Federal Prison System / Bureau Of Prisons | PRIME VENDOR PHARMACEUTICAL FOR THE MDC BROOKLYN INMATE POPULATION | — | USD 894,494 | 0 | — | — |
| 15B60826F00000046 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON PHARMACUTICALS | — | USD 829,405 | 0 | — | — |
| 15B41826F00000054 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON REGULAR MEDICATION JAN26 | — | USD 825,521 | 0 | — | — |
| 15B31026F00000002 | Federal Prison System / Bureau Of Prisons | FY26 REGULAR MEDICATION (13F) - NOVEMBER 2025 -SEPTEMBER 2026 | — | USD 805,194 | 0 | — | — |
| 15B50126F00000070 | Federal Prison System / Bureau Of Prisons | MARCH MCKESSON CONTRACT MEDICATIONS FY26 | — | USD 780,928 | 0 | — | — |
| 15B50726F00000015 | Federal Prison System / Bureau Of Prisons | MCKESSON PRIME | — | USD 760,804 | 0 | — | — |
| 15B20126F00000057 | Federal Prison System / Bureau Of Prisons | 2ND QUARTER REGULAR DRUGS COVERING 1/01/2026 THROUGH 3/31/2026 DELIVERY DATES FROM 1/01/2026 THROUGH 3/31/202… | — | USD 750,000 | 0 | — | — |
| 15B30226F00000093 | Federal Prison System / Bureau Of Prisons | MCKESSON REGULAR MEDICATION AUGUST 2026 FISCAL YEAR 2026 RP#: 0167-26 | — | USD 741,496 | 0 | — | — |
| 15B51826F00000014 | Federal Prison System / Bureau Of Prisons | PROVIDE VARIOUS REGULAR MEDICATION FOR THE INMATE POPULATION AT FCC OAKDALE FOR FY26. | — | USD 727,616 | 0 | — | — |
| 15B10926F00000134 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES | — | USD 724,393 | 0 | — | — |
| 15B21726F00000006 | Federal Prison System / Bureau Of Prisons | INMATE MEDICATION FY26 | — | USD 712,496 | 0 | — | — |
| 15B41926F00000102 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON CONTRACT MEDICATIONS QTR 4 | — | USD 699,588 | 0 | — | — |
| 15B10926F00000057 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES | — | USD 696,289 | 0 | — | — |
| 15B30226F00000095 | Federal Prison System / Bureau Of Prisons | MCKESSON REGULAR MEDICATION SEPTEMBER 2026 FISCAL YEAR 2026 RP#: 0169-26 | — | USD 692,536 | 0 | — | — |
| 15B30226F00000085 | Federal Prison System / Bureau Of Prisons | MCKESSON REGULAR MEDICATION APRIL 2026 FISCAL YEAR 2026 RP#: 0159-26 | — | USD 690,388 | 0 | — | — |
| 15B10926F00000133 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES | — | USD 687,953 | 0 | — | — |
| 15B10926F00000082 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES | — | USD 684,907 | 0 | — | — |
| 15B20126F00000023 | Federal Prison System / Bureau Of Prisons | 1ST QUARTER REGULAR DRUGS COVERING 10/01/2025 THROUGH 12/31/2025 DELIVERY DATES FROM 10/01/2025 THROUGH 12/31… | — | USD 680,000 | 0 | — | — |
| 15B11926F00000029 | Federal Prison System / Bureau Of Prisons | FY26 MCKESSON MAT CONTRACT #36W79720D0001 | — | USD 677,866 | 0 | — | — |
| 15B60626F00000005 | Federal Prison System / Bureau Of Prisons | B1 - FY26 MCKESSON SAM OK | — | USD 665,000 | 0 | — | — |
| 15B10926F00000064 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES - ROUTINE WHOLESALE MEDICATION PURCHASES (MULTIPLE INVOI… | — | USD 646,780 | 0 | — | — |
| 15B31526F00000001 | Federal Prison System / Bureau Of Prisons | MEDICATION FOR THE INMATE POPULATION AT FCC YAZOO CITY FOR THE PERIOD OF PERFORMANCE: OCTOBER 1, 2025 - SEPTE… | — | USD 640,000 | 0 | — | — |
| 15B31426F00000053 | Federal Prison System / Bureau Of Prisons | B1- FY26 MCKESSON CONTRACT MEDICATION | — | USD 630,000 | 0 | — | — |
| 15B50226F00000012 | Federal Prison System / Bureau Of Prisons | FY 2026 NON-CONTROLLED PHARMACEUTICALS OCT. 2025 - JANUARY 30, 2026 | — | USD 604,462 | 0 | — | — |
| 15B41826F00000040 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON REGULAR MEDICATION DEC25 | — | USD 601,052 | 0 | — | — |
| 15B30226F00000091 | Federal Prison System / Bureau Of Prisons | MCKESSON REGULAR MEDICATION JULY 2026 FISCAL YEAR 2026 RP#: 0165-26 | — | USD 599,304 | 0 | — | — |
| 15B10926F00000061 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES | — | USD 599,111 | 0 | — | — |
| 15B30226F00000087 | Federal Prison System / Bureau Of Prisons | MCKESSON REGULAR MEDICATION MAY 2026 FISCAL YEAR 2026 RP#: 0161-26 | — | USD 582,727 | 0 | — | — |
| 15B40926F00000144 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON MEDICATION QTR 4 MEDICATION FOR INMATE HEALTHCARE | — | USD 573,353 | 0 | — | — |
| 15B10926F00000024 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES | — | USD 573,127 | 0 | — | — |
| 15B30226F00000064 | Federal Prison System / Bureau Of Prisons | MCKESSON REGULAR MEDICATION JANUARY 2025 FISCAL YEAR 2026 RP#: 0109-26 | — | USD 562,494 | 0 | — | — |
| 15B50826F00000004 | Federal Prison System / Bureau Of Prisons | REFERENCE CONTRACT #36W79720D0001, MCKESSON CORP. FOR INMATE PHARMACEUTICALS FOR A SERVICE PERIOD OF JANUARY… | — | USD 553,396 | 0 | — | — |
| 15B21526F00000091 | Federal Prison System / Bureau Of Prisons | MCKESSON FY26 MEDICATIONS | — | USD 552,393 | 0 | — | — |
| 15B41926F00000058 | Federal Prison System / Bureau Of Prisons | FCI THOMSON MCKESSON PHARMACEUTICALS ORDER FOR QUARTER THREE OF FY26. ORDER PLACED AGAINST CONTRACT 36W79720D… | — | USD 550,505 | 0 | — | — |
| 15B41826F00000025 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON REGULAR MEDICATION NOV25 | — | USD 546,424 | 0 | — | — |
| 15B50826F00000084 | Federal Prison System / Bureau Of Prisons | REFERENCE CONTRACT #36W79720D0001, MCKESSON CORP. FOR INMATE PHARMACEUTICALS FOR A SERVICE PERIOD OF JULY 1,… | — | USD 545,000 | 0 | — | — |
| 15B10926F00000011 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES - ROUTINE WHOLESALE MEDICATION PURCHASES (MULTIPLE INVOI… | — | USD 543,762 | 0 | — | — |
| 15B11926F00000010 | Federal Prison System / Bureau Of Prisons | FY26 MCKESSON GENERAL MEDICATIONS 10.01.25 - 01.31.26 CONTRACT #36W79720D0001 (VA IAA) | — | USD 537,996 | 0 | — | — |
| 15B10926F00000003 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES - ROUTINE WHOLESALE MEDICATION PURCHASES (MULTIPLE INVOI… | — | USD 532,652 | 0 | — | — |
| 15B61726F00000008 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON REGULAR MEDICATIONS DEC | — | USD 520,620 | 0 | — | — |
| 15B51826F00000092 | Federal Prison System / Bureau Of Prisons | PROVIDE VARIOUS REGULAR MEDICATION FOR THE INMATE POPULATION AT FCC OAKDALE FOR FY26. | — | USD 508,302 | 0 | — | — |
| 15B41226F00000041 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON LD - PRIME VENDOR DEC 25 | — | USD 502,733 | 0 | — | — |
| 15B20127F00000020 | Federal Prison System / Bureau Of Prisons | 1ST QUARTER REGULAR DRUGS COVERING 10/01/2026 THROUGH 12/31/2026 DELIVERY DATES FROM 10/01/2026 THROUGH 12/31… | — | USD 500,000 | 0 | — | — |
| 75H71126F80007 | Indian Health Service | PHARMACEUTICAL SUPPLIES. PHARMACY PRIME VENDOR PURCHASES FOR NSSC FEDERAL CUSTOMERS. | — | USD 500,000 | 0 | — | — |
| 15B51926F00000108 | Federal Prison System / Bureau Of Prisons | JUNE MONTHLY MEDICATIONS FOR INMATES HOUSED AT FCC POLLOCK | — | USD 500,000 | 0 | — | — |